Endometrioid Carcinoma

An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.

Also Known As:

Carcinoma, Endometrioid; Adenocarcinoma, Endometrioid; Endometrioid Adenocarcinoma; Adenocarcinomas, Endometrioid; Carcinomas, Endometrioid; Endometrioid Adenocarcinomas; Endometrioid Carcinomas

Neoplasms: 1324753
- Neoplasms by Site: 4
  - Urogenital Neoplasms: 471
    - Female Genital Neoplasms: 105
      - Uterine Neoplasms: 1516
        Endometrial Neoplasms: 16724
        Endometrioid Carcinoma: 1149
- Neoplasms by Histologic Type: 2
  - Glandular and Epithelial Neoplasms: 439
    - Carcinoma: 141855
      - Adenocarcinoma: 58365
        Endometrioid Carcinoma: 1149
Urogenital Diseases: 126
- Urogenital Neoplasms: 471
  - Female Genital Neoplasms: 105
    - Ovarian Neoplasms: 39416
      - Endometrioid Carcinoma: 1149
    - Uterine Neoplasms: 1516
      - Endometrial Neoplasms: 16724
        Endometrioid Carcinoma: 1149
- Genital Diseases: 114
  - Female Genital Diseases: 393
    - Adnexal Diseases: 60
      - Ovarian Diseases: 665
        Ovarian Neoplasms: 39416
        Endometrioid Carcinoma: 1149
- Female Urogenital Diseases and Pregnancy Complications
  - Female Urogenital Diseases
    - Urogenital Neoplasms: 471
      - Female Genital Neoplasms: 105
        Ovarian Neoplasms: 39416
        Endometrioid Carcinoma: 1149
        Uterine Neoplasms: 1516
        Endometrial Neoplasms: 16724
        Endometrioid Carcinoma: 1149
    - Female Genital Diseases: 393
      - Adnexal Diseases: 60
        Ovarian Diseases: 665
        Ovarian Neoplasms: 39416
        Endometrioid Carcinoma: 1149
Endocrine System Diseases: 968
- Gonadal Disorders: 30
  - Ovarian Diseases: 665
    - Ovarian Neoplasms: 39416
      - Endometrioid Carcinoma: 1149

Zhanshu Ma Selected Research

Zhanshu Ma Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure